PRESERFLO® MicroShunt Extension Study

Status Completed

Clinical Trial Summary

This prospective, concurrent controlled, open-label, multicenter study is designed to collect additional safety data through 5 years of follow-up for subjects randomized to either the treatment arm (PRESERFLO® MicroShunt with MMC) or the control arm (Trabeculectomy with MMC) of the INN-005 clinical study.

Clinical Trial Description

The objective of this study is to evaluate the long-term safety of the PRESERFLO® MicroShunt in subjects with Primary Open-Angle Glaucoma who have completed their Month 24 Follow-Up Visit in the INN-005 clinical study, by collecting safety data through 5 years post-operative follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04333433
Study type	Observational
Source	InnFocus Inc.
Contact
Status	Completed
Phase
Start date	May 22, 2020
Completion date	November 24, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01841437` - Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry	N/A
Completed	`NCT02077231` - Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients	N/A
Completed	`NCT01410188` - Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension	Phase 1/Phase 2
Recruiting	`NCT05557058` - GORE Glaucoma Drainage Implant Clinical Study	N/A
Not yet recruiting	`NCT03924544` - Decorin in Sub Scleral Trabeculectomy	Phase 1
Active, not recruiting	`NCT03673644` - Impact of Glaucoma and Visual Field Loss on Life Space
Completed	`NCT03365778` - Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment	N/A
Completed	`NCT01915940` - Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension	Phase 2
Completed	`NCT03889652` - Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction
Terminated	`NCT03273907` - Post Approval Study of the CyPass System	N/A
Recruiting	`NCT03193333` - PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)	Phase 3
Recruiting	`NCT03921931` - Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study	N/A
Not yet recruiting	`NCT04609345` - Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Recruiting	`NCT05264818` - Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
Enrolling by invitation	`NCT02144103` - Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration	Phase 1/Phase 2
Completed	`NCT01281020` - Adherence With Fixed Versus Unfixed Glaucoma Therapy
Recruiting	`NCT04891588` - Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD	N/A
Completed	`NCT03145129` - PAIR Study-PAP And IOP Relationship: Study 2
Completed	`NCT03104621` - Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients	Phase 4
Completed	`NCT01528111` - Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension	Phase 1/Phase 2